Effectiveness of SGLT2 inhibitors compared to sulphonylureas for long-term glycemic control in type 2 diabetes: A meta-analysis
Sulphonylureas (SUs) are common glucose-lowering agents used for managing type 2 diabetes mellitus (T2DM). However, their long-term effectiveness is often limited due to declining β-cell function. Sodium-glucose co-transporter 2 (SGLT2) inhibitors act independently of insulin, potentially providing...
Saved in:
| Main Authors: | Zhouhong Zhan, Jialiang Wang, Nannan Shen, Xinwen Liu, Lihong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2025-07-01
|
| Series: | Biomolecules & Biomedicine |
| Subjects: | |
| Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/12658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of insulin prescriptions and their association with glycemic control in adults with type 2 diabetes mellitus
by: Helen Chen, et al.
Published: (2025-07-01) -
What’s the latest on sulphonylureas in the management of type 2 diabetes?
by: Gail Mkele
Published: (2013-12-01) -
Efficacy and Safety of Bexagliflozin, a Selective Sodium-Glucose Cotransporter-2 Inhibitor, in Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: A.B.M. Kamrul-Hasan, et al.
Published: (2025-01-01) -
Where do sulphonylureas fit in the type 2 diabetes guidelines?
by: Gail Mkele
Published: (2014-07-01) -
Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus—Randomized Controlled Trial
by: Venkata Chaithanya, et al.
Published: (2024-11-01)